Haemonetics Statistics Share Statistics Haemonetics has 48.04M
shares outstanding. The number of shares has increased by -6.14%
in one year.
Shares Outstanding 48.04M Shares Change (YoY) -6.14% Shares Change (QoQ) -4.38% Owned by Institutions (%) 99.99% Shares Floating 47.51M Failed to Deliver (FTD) Shares 45 FTD / Avg. Volume 0.01%
Short Selling Information The latest short interest is 3.5M, so 7.29% of the outstanding
shares have been sold short.
Short Interest 3.5M Short % of Shares Out 7.29% Short % of Float 11.84% Short Ratio (days to cover) 6.23
Valuation Ratios The PE ratio is 18.97 and the forward
PE ratio is 11.12.
Haemonetics's PEG ratio is
0.44.
PE Ratio 18.97 Forward PE 11.12 PS Ratio 2.34 Forward PS 1.9 PB Ratio 3.87 P/FCF Ratio 22.33 PEG Ratio 0.44
Financial Ratio History Enterprise Valuation Haemonetics has an Enterprise Value (EV) of 4.1B.
EV / Sales 3.01 EV / EBITDA 12.15 EV / EBIT 22.55 EV / FCF 28.77
Financial Position The company has a current ratio of 1.62,
with a Debt / Equity ratio of 1.49.
Current Ratio 1.62 Quick Ratio 0.99 Debt / Equity 1.49 Debt / EBITDA 3.63 Debt / FCF 8.6 Interest Coverage -22.76
Financial Efficiency Return on Equity is 20.43% and Return on Invested Capital is 8.06%.
Return on Equity 20.43% Return on Assets 6.84% Return on Invested Capital 8.06% Revenue Per Employee $372.11K Profits Per Employee $45.85K Employee Count 3,657 Asset Turnover 0.56 Inventory Turnover 1.68
Taxes Income Tax 44.39M Effective Tax Rate 20.93%
Stock Price Statistics The stock price has increased by -29.72% in the
last 52 weeks. The beta is 0.4, so Haemonetics's
price volatility has been higher than the market average.
Beta 0.4 52-Week Price Change -29.72% 50-Day Moving Average 72.62 200-Day Moving Average 71.61 Relative Strength Index (RSI) 18.64 Average Volume (20 Days) 660,140
Income Statement In the last 12 months, Haemonetics had revenue of 1.36B
and earned 167.68M
in profits. Earnings per share was 3.31.
Revenue 1.36B Gross Profit 748.96M Operating Income 221.82M Net Income 167.68M EBITDA 337.4M EBIT 221.82M Earnings Per Share (EPS) 3.31
Full Income Statement Balance Sheet The company has 306.76M in cash and 1.22B in
debt, giving a net cash position of -918.02M.
Cash & Cash Equivalents 306.76M Total Debt 1.22B Net Cash -918.02M Retained Earnings 352.17M Total Assets 2.46B Working Capital 381.75M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was 181.72M
and capital expenditures -39.28M, giving a free cash flow of 142.45M.
Operating Cash Flow 181.72M Capital Expenditures -39.28M Free Cash Flow 142.45M FCF Per Share 2.83
Full Cash Flow Statement Margins Gross margin is 55.04%, with operating and profit margins of 16.3% and 12.32%.
Gross Margin 55.04% Operating Margin 16.3% Pretax Margin 15.58% Profit Margin 12.32% EBITDA Margin 24.79% EBIT Margin 16.3% FCF Margin 10.47%
Dividends & Yields HAE does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield 5.27% FCF Yield 4.48%
Dividend Details Analyst Forecast The average price target for HAE is $86,
which is 63.9% higher than the current price. The consensus rating is "Buy".
Price Target $86 Price Target Difference 63.9% Analyst Consensus Buy Analyst Count 11
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value $53.26 Lynch Upside 1.51% Graham Number 34.96 Graham Upside -33.37%
Stock Splits The last stock split was on Dec 3, 2012. It was a
forward
split with a ratio of 2:1.
Last Split Date Dec 3, 2012 Split Type forward Split Ratio 2:1
Scores Altman Z-Score 2.25 Piotroski F-Score 7
